{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T04:37:55Z","timestamp":1718167075911},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.lfs.2012.10.022","type":"journal-article","created":{"date-parts":[[2012,11,7]],"date-time":"2012-11-07T21:45:14Z","timestamp":1352324714000},"page":"26-34","source":"Crossref","is-referenced-by-count":9,"title":["Fenofibrate reduces cardiac remodeling and improves cardiac function in a rat model of severe left ventricle volume overload"],"prefix":"10.1016","volume":"92","author":[{"given":"Wahiba","family":"Dhahri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Couet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9lise","family":"Roussel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Claude","family":"Drolet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Arsenault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2012.10.022_bb0005","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11906-004-0036-2","article-title":"Energy substrate metabolism in cardiac hypertrophy","volume":"6","author":"Allard","year":"2004","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.lfs.2012.10.022_bb0010","doi-asserted-by":"crossref","first-page":"H140","DOI":"10.1152\/ajpheart.00424.2006","article-title":"AMPK and metabolic adaptation by the heart to pressure overload","volume":"292","author":"Allard","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.lfs.2012.10.022_bb0015","first-page":"128","article-title":"Experimental aortic regurgitation in rats under echocardiographic guidance","volume":"11","author":"Arsenault","year":"2002","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.lfs.2012.10.022_bb0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.phrs.2010.11.002","article-title":"Pleiotropic actions of fenofibrate on the heart","volume":"63","author":"Balakumar","year":"2011","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.lfs.2012.10.022_bb0025","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1050-1738(00)00077-3","article-title":"PPAR signaling in the control of cardiac energy metabolism","volume":"10","author":"Barger","year":"2000","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.lfs.2012.10.022_bb0030","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1172\/JCI9056","article-title":"Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth","volume":"105","author":"Barger","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lfs.2012.10.022_bb0035","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The mechanisms of action of PPARs","volume":"53","author":"Berger","year":"2002","journal-title":"Annu Rev Med"},{"issue":"Pt. C","key":"10.1016\/j.lfs.2012.10.022_bb0040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0076-6879(81)71044-9","article-title":"Peroxisomal and microsomal carnitine acetyltransferases","volume":"71","author":"Bieber","year":"1981","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.lfs.2012.10.022_bb0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11936-000-0005-2","article-title":"Aortic regurgitation","volume":"2","author":"Bonow","year":"2000","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.lfs.2012.10.022_bb0050","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1161\/01.CIR.84.4.1625","article-title":"Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function","volume":"84","author":"Bonow","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2012.10.022_bb0055","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1161\/CIRCULATIONAHA.106.176857","volume":"114","author":"Bonow","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2012.10.022_bb0060","doi-asserted-by":"crossref","first-page":"H125","DOI":"10.1152\/ajpheart.00199.2010","article-title":"A high fructose diet worsens eccentric left ventricular hypertrophy in experimental volume overload","volume":"300","author":"Bouchard-Thomassin","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.lfs.2012.10.022_bb0065","doi-asserted-by":"crossref","first-page":"H669","DOI":"10.1152\/ajpheart.01046.2008","article-title":"Gene profiling of left ventricle eccentric hypertrophy in aortic regurgitation in rats: rationale for targeting the beta-adrenergic and renin-angiotensin systems","volume":"296","author":"Champetier","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.lfs.2012.10.022_bb0070","first-page":"470","article-title":"PPAR alpha activator fenofibrate regressed left ventricular hypertrophy and increased myocardium PPAR alpha expression in spontaneously hypertensive rats","volume":"36","author":"Chen","year":"2007","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.lfs.2012.10.022_bb0075","doi-asserted-by":"crossref","first-page":"H1983","DOI":"10.1152\/ajpheart.00002.2009","article-title":"Fenofibrate inhibits aldosterone-induced apoptosis in adult rat ventricular myocytes via stress-activated kinase-dependent mechanisms","volume":"296","author":"De Silva","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.lfs.2012.10.022_bb0080","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.yjmcc.2003.11.004","article-title":"PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats","volume":"36","author":"Diep","year":"2004","journal-title":"J Mol Cell Cardiol"},{"issue":"Pt. 1","key":"10.1016\/j.lfs.2012.10.022_bb0085","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1042\/bj3240289","article-title":"Tissue-specific regulation of medium-chain acyl-CoA dehydrogenase gene by thyroid hormones in the developing rat","volume":"324","author":"Djouadi","year":"1997","journal-title":"Biochem J"},{"key":"10.1016\/j.lfs.2012.10.022_bb0090","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/HYPERTENSIONAHA.107.086926","article-title":"Peroxisome proliferator-activated receptor alpha-independent actions of fenofibrate exacerbates left ventricular dilation and fibrosis in chronic pressure overload","volume":"49","author":"Duhaney","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2012.10.022_bb0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1113\/jphysiol.2006.109389","article-title":"AMPK alterations in cardiac physiology and pathology: enemy or ally?","volume":"574","author":"Dyck","year":"2006","journal-title":"J Physiol"},{"key":"10.1016\/j.lfs.2012.10.022_bb0100","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.nut.2008.12.010","article-title":"Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet","volume":"25","author":"Fernandes-Santos","year":"2009","journal-title":"Nutrition"},{"key":"10.1016\/j.lfs.2012.10.022_bb0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1042\/0264-6021:3500061","article-title":"Malonyl-CoA metabolism in cardiac myocytes","volume":"350Pt 1","author":"Hamilton","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.lfs.2012.10.022_bb0115","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bbrc.2010.03.043","article-title":"PPARalpha agonist fenofibrate protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress and MAPK activity","volume":"394","author":"Hou","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.lfs.2012.10.022_bb0120","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/01.HYP.0000083511.91817.B1","article-title":"Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension","volume":"42","author":"Iglarz","year":"2003","journal-title":"Hypertension"},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2012.10.022_bb0125","doi-asserted-by":"crossref","first-page":"S358","DOI":"10.1097\/01.fjc.0000166303.33313.01","article-title":"Activation of peroxisome proliferator-activated receptor-alpha decreases endothelin-1-induced p38 mitogen-activated protein kinase activation in cardiomyocytes","volume":"44","author":"Irukayama-Tomobe","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.lfs.2012.10.022_bb0130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/jpet.106.116871","article-title":"Chronic activation of peroxisome proliferator-activated receptor-alpha with fenofibrate prevents alterations in cardiac metabolic phenotype without changing the onset of decompensation in pacing-induced heart failure","volume":"321","author":"Labinskyy","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.lfs.2012.10.022_bb0140","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1249\/MSS.0b013e318195b938","article-title":"Effects of exercise in volume overload: insights from a model of aortic regurgitation","volume":"41","author":"Lachance","year":"2009","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.lfs.2012.10.022_bb0145","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCHEARTFAILURE.108.845487","article-title":"Moderate exercise training improves survival and ventricular remodeling in an animal model of left ventricular volume overload","volume":"2","author":"Lachance","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.lfs.2012.10.022_bb0150","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/HYPERTENSIONAHA.107.092403","article-title":"Effects of fenofibrate on cardiac remodeling in aldosterone-induced hypertension","volume":"50","author":"Lebrasseur","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2012.10.022_bb0155","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1111\/j.1582-4934.2008.00484.x","article-title":"Effects and mechanisms of PPARalpha activator fenofibrate on myocardial remodelling in hypertension","volume":"13","author":"Li","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.lfs.2012.10.022_bb0160","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.yjmcc.2003.10.001","article-title":"Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models","volume":"35","author":"Liang","year":"2003","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.lfs.2012.10.022_bb0165","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1210\/me.2009-0374","article-title":"Minireview: Won't get fooled again: the nonmetabolic roles of peroxisome proliferator-activated receptors (PPARs) in the heart","volume":"24","author":"Lockyer","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.lfs.2012.10.022_bb0170","doi-asserted-by":"crossref","first-page":"10611","DOI":"10.1128\/MCB.24.24.10611-10620.2004","article-title":"p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload","volume":"24","author":"Nishida","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"Suppl. 48","key":"10.1016\/j.lfs.2012.10.022_bb0175","doi-asserted-by":"crossref","first-page":"284S","DOI":"10.1042\/CS103S284S","article-title":"Stimulation of peroxisome-proliferator-activated receptor alpha (PPAR alpha) attenuates cardiac fibrosis and endothelin-1 production in pressure-overloaded rat hearts","volume":"103","author":"Ogata","year":"2002","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.lfs.2012.10.022_bb0180","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1054\/jcaf.2003.17","article-title":"Left ventricular response to sustained volume overload from chronic aortic valve regurgitation in rats","volume":"9","author":"Plante","year":"2003","journal-title":"J Card Fail"},{"key":"10.1016\/j.lfs.2012.10.022_bb0185","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1139\/y04-005","article-title":"Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation","volume":"82","author":"Plante","year":"2004","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.lfs.2012.10.022_bb0190","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/01.CIR.0000141733.55236.9D","article-title":"Effectiveness of beta-blockade in experimental chronic aortic regurgitation","volume":"110","author":"Plante","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2012.10.022_bb0195","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.echo.2006.06.011","article-title":"Impact of anesthesia on echocardiographic evaluation of systolic and diastolic function in rats","volume":"19","author":"Plante","year":"2006","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.lfs.2012.10.022_bb0200","doi-asserted-by":"crossref","first-page":"H1888","DOI":"10.1152\/ajpheart.01286.2007","article-title":"Benefits of long-term {beta}-blockade in experimental chronic aortic regurgitation","volume":"294","author":"Plante","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.lfs.2012.10.022_bb0205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCHEARTFAILURE.108.801548","article-title":"Comparative study of vasodilators in an animal model of chronic volume overload caused by severe aortic regurgitation","volume":"2","author":"Plante","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.lfs.2012.10.022_bb0210","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/FJC.0b013e31822368d7","article-title":"Reactivation of peroxisome proliferator-activated receptor alpha in spontaneously hypertensive rat: age-associated paradoxical effect on the heart","volume":"58","author":"Purushothaman","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.lfs.2012.10.022_bb0215","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000103917","article-title":"Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats","volume":"80","author":"Rose","year":"2007","journal-title":"Pharmacology"},{"key":"10.1016\/j.lfs.2012.10.022_bb0220","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI0214938","article-title":"The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy","volume":"110","author":"Sadoshima","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lfs.2012.10.022_bb0225","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1015380609464","article-title":"Energy metabolism in the hypertrophied heart","volume":"7","author":"Sambandam","year":"2002","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.lfs.2012.10.022_bb0235","doi-asserted-by":"crossref","first-page":"44390","DOI":"10.1074\/jbc.M103826200","article-title":"Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart","volume":"276","author":"Young","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lfs.2012.10.022_bb0240","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/CIRCHEARTFAILURE.110.958512","article-title":"Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation","volume":"4","author":"Zendaoui","year":"2011","journal-title":"Circ Heart Fail"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320512006492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320512006492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T16:28:36Z","timestamp":1540139316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320512006492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0024320512006492"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2012.10.022","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}